HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HAIXI PHARMA

163.000

-3.000-1.81%

Volume:200

Turnover:32.76K

Market Cap:12.83B

PE:54.63

High:166.000

Open:166.000

Low:163.000

Close:166.000

52wk High:302.400

52wk Low:97.500

Shares:78.71M

HK Float Shares:78.71M

Volume Ratio:0.00

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(LYR):2.984

ROE:16.58%

ROA:9.23%

PB:6.57

PE(LYR):54.63

PS:18.46

Loading ...

Overview Company News Filings

HAIXI PHARMA Releases 2025 ESG Report, Sets 5% Carbon-Intensity Cut by 2030 and Highlights Zero Safety, Recall or Corruption Incidents

Bulletin Express

海西医药2025年业绩大增，营收同比增长24.8%至人民币5.82358亿元，持续加码双轨研发与全球化拓展

Bulletin Express

Fujian Haixi Pharmaceuticals publishes 2025 annual report

HAIXI PHARMA Proposes Adoption of H-Share Incentive Scheme

Fujian Haixi Pharma proposes H-share incentive scheme funded by existing shares

Stock Track | Haixi Pharma Soars 7.66% Intraday on Broker Initiation, Strong Financials and Positive Clinical Data

Haixi Pharma Adopts Full Electronic Dissemination of Corporate Communications

Bulletin Express

Haixi Pharma Shifts to Fully Electronic Distribution of Corporate Communications

Bulletin Express

Stock Track | Haixi Pharma Soars 5.06% Intraday on Broker Buy Rating and Strong Drug Pipeline Progress

Stock Track | Haixi Pharma Soars 14.56% Intraday on First Broker Coverage and Pipeline Optimism

HAIXI PHARMA Surges Over 7% to Record High as HXP056 Nears Key Data Milestone

HAIXI PHARMA Shares Surge Over 4% as HXP056 Shows Significant Inhibition of Fundus Leakage; Potential to Reshape wAMD Treatment Landscape Upon Success

HAIXI PHARMA Maintains 78.71 Million Issued Shares in March 2026; Public Float Meets 25% Threshold

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/02637/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02637","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02637\",,,,,undefined,":{"symbol":"02637","market":"HK","secType":"STK","nameCN":"HAIXI PHARMA","latestPrice":163,"timestamp":1790928300061,"preClose":166,"halted":0,"volume":200,"delay":0,"changeRate":-0.018072289156626505,"floatShares":78707270,"shares":78707270,"eps":2.983617659060234,"marketStatus":"Market Closed","change":-3,"latestTime":"10-02 16:05:00","open":166,"high":166,"low":163,"amount":32760,"amplitude":0.018072,"askPrice":165.9,"askSize":50,"bidPrice":162.8,"bidSize":200,"shortable":3,"etf":0,"ttmEps":2.3363352634577357,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791163800000},"marketStatusCode":7,"adr":0,"listingDate":1760889600000,"exchange":"SEHK","adjPreClose":166,"openAndCloseTimeList":[[1790904600000,1790913600000],[1790917200000,1790928000000]],"volumeRatio":0.003544,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02637\",,,,,undefined,":{"symbol":"02637","floatShares":78707270,"roa":"9.23%","roe":"16.58%","lyrEps":2.983618,"volumeRatio":0.003544,"shares":78707270,"dividePrice":0,"high":166,"amplitude":0.018072,"preClose":166,"low":163,"week52Low":97.5,"pbRate":"6.57","psRate":"18.46","week52High":302.4,"institutionHeld":0,"latestPrice":163,"committee":0.6,"eps":2.983617659060234,"divideRate":0,"volume":200,"delay":0,"ttmEps":2.3363352634577357,"open":166,"prevYearClose":136,"prevWeekClose":172,"prevMonthClose":166,"prevQuarterClose":166,"fiveDayClose":172,"twentyDayClose":203.4,"sixtyDayClose":197.7},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02637\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"02637","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787880600000,"name":null,"time":"","dateTimestamp":1787846400000,"actualEps":null},{"date":"2026-03-30","symbol":"02637","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02637\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02637\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1781107200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02637\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02637","date":"2026-09-30","current":69.767384,"percent":0.562232,"low":41.43616,"twenty":68.63795,"median":73.127384,"eighty":81.974281,"high":108.687128,"avg":74.78197,"sd":9.248122,"marketCap":13065406820},"quantilePoints":[{"date":"2025-10-16","current":41.43616,"twenty":41.43616,"median":41.43616,"eighty":41.43616,"marketCap":6150186077},{"date":"2025-10-24","current":58.044665,"twenty":53.788314,"median":54.742854,"eighty":58.044665,"marketCap":8618446065},{"date":"2025-10-31","current":63.409996,"twenty":54.11413,"median":58.177187,"eighty":60.582738,"marketCap":9429130946},{"date":"2025-11-07","current":65.038519,"twenty":55.071217,"median":59.875924,"eighty":63.533346,"marketCap":9665252756},{"date":"2025-11-14","current":69.713569,"twenty":57.493757,"median":61.562796,"eighty":68.778725,"marketCap":10389359640},{"date":"2025-11-21","current":66.575785,"twenty":58.2567,"median":64.026746,"eighty":69.208194,"marketCap":9917116020},{"date":"2025-11-28","current":68.072175,"twenty":59.478322,"median":65.807152,"eighty":68.767812,"marketCap":10176850011},{"date":"2025-12-05","current":68.42835,"twenty":59.854834,"median":66.893861,"eighty":68.767812,"marketCap":10247686554},{"date":"2025-12-12","current":69.403659,"twenty":60.326406,"median":67.279459,"eighty":69.361692,"marketCap":10412971821},{"date":"2025-12-19","current":69.502155,"twenty":61.237436,"median":67.861589,"eighty":69.423358,"marketCap":10452325456},{"date":"2025-12-24","current":72.521094,"twenty":61.537644,"median":68.055113,"eighty":69.462757,"marketCap":10940310530},{"date":"2026-01-02","current":68.547,"twenty":62.032842,"median":68.254334,"eighty":69.697511,"marketCap":10381488913},{"date":"2026-01-09","current":76.256401,"twenty":63.533346,"median":68.54394,"eighty":70.33117,"marketCap":11577839417},{"date":"2026-01-16","current":83.450154,"twenty":64.030428,"median":68.594109,"eighty":71.180851,"marketCap":12711224105},{"date":"2026-01-23","current":75.203122,"twenty":64.243828,"median":68.851274,"eighty":73.407226,"marketCap":11444037058},{"date":"2026-01-30","current":72.029156,"twenty":65.345972,"median":69.26967,"eighty":73.580372,"marketCap":11011147073},{"date":"2026-02-06","current":69.741329,"twenty":66.631937,"median":69.18814,"eighty":73.524909,"marketCap":10688447266},{"date":"2026-02-13","current":69.700471,"twenty":66.864009,"median":69.376262,"eighty":73.289662,"marketCap":10743542355},{"date":"2026-02-20","current":69.085102,"twenty":66.878935,"median":69.376262,"eighty":72.984771,"marketCap":10633352177},{"date":"2026-02-27","current":72.331605,"twenty":67.046254,"median":69.403659,"eighty":72.584608,"marketCap":11255139610},{"date":"2026-03-06","current":63.89376,"twenty":67.046254,"median":69.448144,"eighty":72.584608,"marketCap":9862020931},{"date":"2026-03-13","current":75.4784,"twenty":67.193436,"median":69.633279,"eighty":73.562991,"marketCap":11703771049},{"date":"2026-03-20","current":69.956787,"twenty":67.26348,"median":69.715081,"eighty":73.483508,"marketCap":10806508171},{"date":"2026-03-27","current":78.768036,"twenty":67.31702,"median":69.741329,"eighty":73.616705,"marketCap":12136661034},{"date":"2026-04-02","current":69.050489,"twenty":67.448055,"median":69.756887,"eighty":73.953025,"marketCap":13907574609},{"date":"2026-04-10","current":75.734842,"twenty":67.617502,"median":69.89051,"eighty":74.51958,"marketCap":15371529831},{"date":"2026-04-17","current":75.664292,"twenty":67.861589,"median":70.029272,"eighty":74.51958,"marketCap":15363659104},{"date":"2026-04-24","current":92.094347,"twenty":68.038051,"median":70.361759,"eighty":74.892793,"marketCap":18700847352},{"date":"2026-04-30","current":101.138303,"twenty":68.06535,"median":70.518529,"eighty":75.515578,"marketCap":20542597470},{"date":"2026-05-08","current":91.134409,"twenty":68.133872,"median":70.614497,"eighty":76.472636,"marketCap":18574915720},{"date":"2026-05-15","current":84.578883,"twenty":68.178204,"median":70.813553,"eighty":78.193464,"marketCap":17284116492},{"date":"2026-05-22","current":93.496946,"twenty":68.295676,"median":71.108793,"eighty":80.407586,"marketCap":19062900794},{"date":"2026-05-29","current":86.09458,"twenty":68.386305,"median":71.340959,"eighty":80.936301,"marketCap":17614687026},{"date":"2026-06-05","current":72.717092,"twenty":68.497704,"median":72.103769,"eighty":80.766638,"marketCap":14899286211},{"date":"2026-06-12","current":67.961351,"twenty":68.497704,"median":71.340959,"eighty":80.580489,"marketCap":13915445336},{"date":"2026-06-18","current":66.149737,"twenty":68.365282,"median":71.108793,"eighty":80.547429,"marketCap":13577004075},{"date":"2026-06-26","current":64.123676,"twenty":68.103023,"median":70.813553,"eighty":80.470686,"marketCap":13096889728},{"date":"2026-07-03","current":76.78307,"twenty":68.156523,"median":70.813553,"eighty":80.277662,"marketCap":15694229638},{"date":"2026-07-10","current":79.190679,"twenty":68.212992,"median":71.108793,"eighty":80.277662,"marketCap":16166473258},{"date":"2026-07-17","current":71.84101,"twenty":68.34426,"median":71.590985,"eighty":79.86919,"marketCap":14718259490},{"date":"2026-07-24","current":70.518964,"twenty":68.451468,"median":71.287767,"eighty":79.796901,"marketCap":14450654772},{"date":"2026-07-31","current":65.554893,"twenty":68.149296,"median":70.906272,"eighty":79.747346,"marketCap":13458943170},{"date":"2026-08-07","current":75.261161,"twenty":68.149296,"median":71.19828,"eighty":79.190679,"marketCap":15481720009},{"date":"2026-08-14","current":78.261297,"twenty":68.185431,"median":71.340959,"eighty":78.768036,"marketCap":16119248896},{"date":"2026-08-21","current":76.639812,"twenty":68.323237,"median":72.054899,"eighty":79.190679,"marketCap":15820161270},{"date":"2026-08-28","current":74.907011,"twenty":68.42835,"median":72.201471,"eighty":78.768036,"marketCap":15465978555},{"date":"2026-09-04","current":89.46632,"twenty":68.54394,"median":72.352576,"eighty":79.884165,"marketCap":15686358911},{"date":"2026-09-11","current":86.521471,"twenty":68.545014,"median":72.521094,"eighty":80.616434,"marketCap":15190503110},{"date":"2026-09-18","current":86.274256,"twenty":68.547,"median":72.698486,"eighty":82.359485,"marketCap":15166890929},{"date":"2026-09-25","current":77.153646,"twenty":68.63305,"median":72.884321,"eighty":82.34846,"marketCap":13537650440},{"date":"2026-09-30","current":74.32358,"twenty":68.63795,"median":73.127384,"eighty":81.974281,"marketCap":13065406820}],"updateTime":1790959264507},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02637\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1189858473","title":"HAIXI PHARMA Releases 2025 ESG Report, Sets 5% Carbon-Intensity Cut by 2030 and Highlights Zero Safety, Recall or Corruption Incidents","url":"https://stock-news.laohu8.com/highlight/detail?id=1189858473","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189858473?lang=en_us&edition=fundamental","pubTime":"2026-04-29 21:24","pubTimestamp":1777469054,"startTime":"0","endTime":"0","summary":"Fujian Haixi Pharmaceuticals Co., Ltd. (HAIXI PHARMA) published its 2025 Environmental, Social and Governance Report covering operations from 1 January 2025 to 31 December 2025. The disclosure...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134020840","title":"海西医药2025年业绩大增，营收同比增长24.8%至人民币5.82358亿元，持续加码双轨研发与全球化拓展","url":"https://stock-news.laohu8.com/highlight/detail?id=1134020840","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134020840?lang=en_us&edition=fundamental","pubTime":"2026-04-29 21:08","pubTimestamp":1777468116,"startTime":"0","endTime":"0","summary":"海西医药在截至2025年12月31日的财务数据显示，公司实现总收入人民币5.82358亿元（下同，以下金额如无特别说明均为已转换的“亿元”单位，即原公告“百万”单位数额÷100），较去年同期的4.66683亿元同比增长24.8%。其中，核心产品表现突出，带动整体业务规模稳步扩张。公司全年毛利为4.85557亿元，同比增长25.4%，毛利率由83.0%上升至83.4%。年内净利润达1.77029亿元...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"海西医药2025年业绩大增，营收同比增长24.8%至人民币5.82358亿元，持续加码双轨研发与全球化拓展","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631514990","title":"Fujian Haixi Pharmaceuticals publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2631514990","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631514990?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:55","pubTimestamp":1777467349,"startTime":"0","endTime":"0","summary":"HXPharma published its 2025 annual report, highlighting continued expansion of commercial footprint in China alongside a dual-track strategy combining generics with in-house innovative R&D.Portfolio reached 15 NMPA-cleared generic drugs, supported by distribution coverage of over 18,000 hospitals and medical institutions.National volume-based procurement products remained main growth drivers, led by Haihuitong and Anbili.Lead oncology candidate C019199 is slated to start Phase III osteosarcoma trials in 1H 2026, positioning it as potential first-in-class therapy.Oral retinal disease candidate HXP056 moved into Phase II in 4Q 2025, with US and China studies planned in 2026 for nAMD and DME.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL5CrSfQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143765846","title":"HAIXI PHARMA Proposes Adoption of H-Share Incentive Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1143765846","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143765846?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:52","pubTimestamp":1777467143,"startTime":"0","endTime":"0","summary":"HAIXI PHARMA (02637) has announced that on April 29, 2026, the board of directors passed a resolution proposing the adoption of a share incentive plan applicable to the company's H-shares. The share...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631514316","title":"Fujian Haixi Pharma proposes H-share incentive scheme funded by existing shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2631514316","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631514316?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:49","pubTimestamp":1777466955,"startTime":"0","endTime":"0","summary":"Fujian Haixi Pharmaceuticals board moved to adopt a share incentive scheme for H shares on April 29, 2026.Plan will be funded by existing shares, not new share issuance.Implementation requires shareholder approval via special resolution at upcoming annual general meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fujian Haixi Pharmaceuticals Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 29, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDLRBdwQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119193958","title":"Stock Track | Haixi Pharma Soars 7.66% Intraday on Broker Initiation, Strong Financials and Positive Clinical Data","url":"https://stock-news.laohu8.com/highlight/detail?id=1119193958","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119193958?lang=en_us&edition=fundamental","pubTime":"2026-04-29 10:00","pubTimestamp":1777428000,"startTime":"0","endTime":"0","summary":"Haixi Pharma's stock surged 7.66% during intraday trading on Wednesday, staging a significant rebound.The movement follows the initiation of coverage by Shenwan Hongyuan with a Buy rating and a...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137771673","title":"Haixi Pharma Adopts Full Electronic Dissemination of Corporate Communications","url":"https://stock-news.laohu8.com/highlight/detail?id=1137771673","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137771673?lang=en_us&edition=fundamental","pubTime":"2026-04-28 21:24","pubTimestamp":1777382666,"startTime":"0","endTime":"0","summary":"Fujian Haixi Pharmaceuticals Co., Ltd. (Haixi Pharma) confirmed a transition to electronic delivery for all future corporate communications in line with Rule 2.07A of the Hong Kong Stock Exchange...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165703728","title":"Haixi Pharma Shifts to Fully Electronic Distribution of Corporate Communications","url":"https://stock-news.laohu8.com/highlight/detail?id=1165703728","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165703728?lang=en_us&edition=fundamental","pubTime":"2026-04-28 21:23","pubTimestamp":1777382623,"startTime":"0","endTime":"0","summary":"Fujian Haixi Pharmaceuticals Co., Ltd. (Haixi Pharma, 02637) has announced that, effective 30 April 2026, all future corporate communications will be disseminated exclusively via electronic channels...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141705590","title":"Stock Track | Haixi Pharma Soars 5.06% Intraday on Broker Buy Rating and Strong Drug Pipeline Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=1141705590","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141705590?lang=en_us&edition=fundamental","pubTime":"2026-04-28 09:48","pubTimestamp":1777340905,"startTime":"0","endTime":"0","summary":"Haixi Pharma's stock surged 5.06% during intraday trading on Tuesday, continuing its strong performance this year.The price movement follows Shenwan Hongyuan's initiation of coverage on the company...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120458534","title":"Stock Track | Haixi Pharma Soars 14.56% Intraday on First Broker Coverage and Pipeline Optimism","url":"https://stock-news.laohu8.com/highlight/detail?id=1120458534","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120458534?lang=en_us&edition=fundamental","pubTime":"2026-04-27 09:51","pubTimestamp":1777254687,"startTime":"0","endTime":"0","summary":"Haixi Pharma's stock surged 14.56% during intraday trading on Monday, marking a significant upward movement.The rally was primarily driven by Shenwan Hongyuan's first-ever coverage of the company,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113832302","title":"HAIXI PHARMA Surges Over 7% to Record High as HXP056 Nears Key Data Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=1113832302","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113832302?lang=en_us&edition=fundamental","pubTime":"2026-04-24 10:38","pubTimestamp":1776998304,"startTime":"0","endTime":"0","summary":"HAIXI PHARMA (02637) rose more than 7%, reaching an intraday high of HKD 230.4, a new record. At the time of writing, the stock was up 7.42% to HKD 228.8, with a turnover of HKD 53.3445 million. The...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK4585","BK4588","02637","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176595853","title":"HAIXI PHARMA Shares Surge Over 4% as HXP056 Shows Significant Inhibition of Fundus Leakage; Potential to Reshape wAMD Treatment Landscape Upon Success","url":"https://stock-news.laohu8.com/highlight/detail?id=1176595853","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176595853?lang=en_us&edition=fundamental","pubTime":"2026-04-17 11:10","pubTimestamp":1776395424,"startTime":"0","endTime":"0","summary":"HAIXI PHARMA (02637) rose more than 4%. At the time of writing, the stock was up 3.8%, trading at HK$196.6 with a turnover of HK$28.8643 million. The company previously announced that its innovative...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637","BK1191","VXUS","BK4585","IPOS","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112407237","title":"HAIXI PHARMA Maintains 78.71 Million Issued Shares in March 2026; Public Float Meets 25% Threshold","url":"https://stock-news.laohu8.com/highlight/detail?id=1112407237","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112407237?lang=en_us&edition=fundamental","pubTime":"2026-04-08 17:04","pubTimestamp":1775639074,"startTime":"0","endTime":"0","summary":"Fujian Haixi Pharmaceuticals Co., Ltd. (HAIXI PHARMA) filed its Monthly Return to Hong Kong Exchanges and Clearing for the period ended 31 March 2026, confirming no changes in either authorised or...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":4,"totalSize":73,"code":"91000000","status":"200"}]}}